Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens
Clinical trial NCT04989816 · COMPLETED
Trial details
- NCT number
- NCT04989816
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2023-06-16
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.